Dermata Therapeutics Faces Delisting Notice
Ticker: DRMAW · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: DRMA
TL;DR
DRMA is getting delisted, big trouble.
AI Summary
Dermata Therapeutics, Inc. filed an 8-K on March 25, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in San Diego, California, and its principal executive offices are located at 3525 Del Mar Heights Rd., #322.
Why It Matters
This filing indicates potential issues with Dermata Therapeutics' continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a severe risk to its operations and shareholder value.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- March 25, 2025 (date) — Date of earliest event reported
- San Diego, CA (location) — Principal executive offices location
- 3525 Del Mar Heights Rd., #322 (address) — Principal executive offices address
FAQ
What specific listing rule or standard has Dermata Therapeutics failed to satisfy?
The filing does not specify the exact rule or standard that Dermata Therapeutics has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 25, 2025.
Where are Dermata Therapeutics' principal executive offices located?
Dermata Therapeutics' principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
What is the Commission File Number for Dermata Therapeutics?
The Commission File Number for Dermata Therapeutics is 001-40739.
What is the Standard Industrial Classification code for Dermata Therapeutics?
The Standard Industrial Classification code for Dermata Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).